Articoli con mandati relativi all'accesso pubblico - Daniel D. BuchananUlteriori informazioni
TotaleNIHNHMRCCancer Research UKMRCNIHRCIHRGovernment of SpainEuropean CommissionDFGBMBFSwedish Research CouncilWellcomeCCSWorld Cancer Researh Fund, UKINSERMHelmholtzFondazione AIRC per la Ricerca sul CancroKWFGoverno ItalianoAcademy of FinlandDamon Runyon Cancer Research FoundationKnut and Alice Wallenberg FoundationOICRNordforskFWFGenome CanadaState of CalifoniaFlorida Department of Health, USADoDCSOSCLSusan G. KomenARCNSFCESRCZonMwRCNA*StarBreast Cancer Now, UKProstate Cancer UKFAPESPBBSRCDiabetes UKWorldwide Cancer Research, UKNMRCVAFWONSERCDFFBanking Foundation "la Caixa"OTKAAcademy of Medical Sciences, UKVersus Arthritis, UKBHFEPSRCANRUK Research & InnovationV Foundation, USAHealth Data Research, UKGovernment of ArgentinaHealth and Care Research Wales
Non disponibili pubblicamente: 8
Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study
DD Buchanan, M Clendenning, L Zhuoer, JR Stewart, S Joseland, ...
Gut 66 (6), 1170-1172, 2017
Mandati: National Health and Medical Research Council, Australia
Improving identification of lynch syndrome patients: A comparison of research data with clinical records
YY Tan, J McGaughran, K Ferguson, MD Walsh, DD Buchanan, JP Young, ...
International journal of cancer 132 (12), 2876-2883, 2013
Mandati: National Health and Medical Research Council, Australia
Phenotypic confirmation of oligodontia, colorectal polyposis and cancer in a family carrying an exon 7 nonsense variant in the AXIN2 gene
C Beard, R Purvis, IM Winship, FA Macrae, DD Buchanan
Familial Cancer 18, 311-315, 2019
Mandati: National Health and Medical Research Council, Australia
A genomic test for colorectal cancer risk: is this acceptable and feasible in primary care?
S Saya, JG McIntosh, IM Winship, M Clendenning, S Milton, J Oberoi, ...
Public Health Genomics 23 (3-4), 110-121, 2020
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer
JM Chan, M Clendenning, S Joseland, P Georgeson, K Mahmood, ...
Familial Cancer, 1-15, 2022
Mandati: National Health and Medical Research Council, Australia
Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practice
S Saya, JG McIntosh, IM Winship, S Milton, M Clendenning, M Kyriakides, ...
Patient Education and Counseling 105 (4), 987-995, 2022
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study
JE Joo, H Jayasekara, EM Wong, M Clendenning, C Rosty, IM Winship, ...
Gut 68 (4), 761-762, 2019
Mandati: National Health and Medical Research Council, Australia
Waist circumference, a body shape index, and molecular subtypes of colorectal cancer: A pooled analysis of four cohort studies
CV Chalitsios, G Markozannes, C Papagiannopoulos, EK Aglago, ...
Cancer Epidemiology, Biomarkers & Prevention, 2025
Mandati: National Health and Medical Research Council, Australia, Cancer Research UK
Disponibili pubblicamente: 268
Identification of Lynch syndrome among patients with colorectal cancer
L Moreira, F Balaguer, N Lindor, A De la Chapelle, H Hampel, ...
Jama 308 (15), 1555-1565, 2012
Mandati: US National Institutes of Health, Government of Spain
Prevalence and penetrance of major genes and polygenes for colorectal cancer
AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (3), 404-412, 2017
Mandati: US National Institutes of Health, National Health and Medical Research …
Discovery of common and rare genetic risk variants for colorectal cancer
JR Huyghe, SA Bien, TA Harrison, HM Kang, S Chen, SL Schmit, ...
Nature genetics 51 (1), 76-87, 2019
Mandati: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Association between molecular subtypes of colorectal cancer and patient survival
AI Phipps, PJ Limburg, JA Baron, AN Burnett-Hartman, DJ Weisenberger, ...
Gastroenterology 148 (1), 77-87. e2, 2015
Mandati: US National Institutes of Health
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
L Baglietto, NM Lindor, JG Dowty, DM White, A Wagner, ...
Journal of the national cancer institute 102 (3), 193-201, 2010
Mandati: US National Institutes of Health, Cancer Research UK, Chief Scientist Office …
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer
D Mouradov, C Sloggett, RN Jorissen, CG Love, S Li, AW Burgess, ...
Cancer research 74 (12), 3238-3247, 2014
Mandati: Australian Research Council, National Health and Medical Research Council …
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
N Papadimitriou, N Dimou, KK Tsilidis, B Banbury, RM Martin, SJ Lewis, ...
Nature communications 11 (1), 597, 2020
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study
AK Win, JP Young, NM Lindor, KM Tucker, DJ Ahnen, GP Young, ...
Journal of clinical oncology 30 (9), 958-964, 2012
Mandati: US National Institutes of Health
Cancer Risks for MLH1 and MSH2 Mutation Carriers
JG Dowty, AK Win, DD Buchanan, NM Lindor, FA Macrae, M Clendenning, ...
Human mutation 34 (3), 490-497, 2013
Mandati: US National Institutes of Health, National Health and Medical Research …
Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors
J Jeon, M Du, RE Schoen, M Hoffmeister, PA Newcomb, SI Berndt, ...
Gastroenterology 154 (8), 2152-2164. e19, 2018
Mandati: US National Institutes of Health, National Health and Medical Research …
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
AI Phipps, DD Buchanan, KW Makar, AK Win, JA Baron, NM Lindor, ...
British journal of cancer 108 (8), 1757-1764, 2013
Mandati: US National Institutes of Health
Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
JN Poynter, KD Siegmund, DJ Weisenberger, TI Long, SN Thibodeau, ...
Cancer Epidemiology Biomarkers & Prevention 17 (11), 3208-3215, 2008
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software